<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2263535795386733843</id><updated>2011-11-27T20:22:53.915-05:00</updated><title type='text'>Prostate Cancer Imaging Forum</title><subtitle type='html'>for patients, technologists, clinicians and radiologists</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://prostate-forum.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>6</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2263535795386733843.post-2128247141282647243</id><published>2008-02-04T19:12:00.001-05:00</published><updated>2008-02-09T14:48:42.820-05:00</updated><title type='text'>"...could the clinical stage be up-graded to reflect a T2 or even T3 classification depending on the imaging results?"</title><content type='html'>&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;".&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;..when prostate cancer is found prior to biopsy, through the application of newer imaging techniques of the prostate, such as dynamic contrast-enhanced MR imaging and 3D MR spectroscopic imaging, and that prostate cancer is confirmed by subsequent biopsy, would the clinical staging, prior to treatment, still remain T1, or could the clinical stage be up-graded to reflect a T2 or even T3 classification depending on the imaging results?"&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"   style="font-style: italic; line-height: 18px; font-family:'trebuchet ms';font-size:48px;"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style="line-height: normal; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;... was asked by David, who posted the following comment:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;G&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;reetings,&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;T1c prostate cancer is diagnosed because of an abnormal PSA in the setting of no palpable abnormality on Digital Rectal Examination and the cancer tumor is found in one or both lobes by needle biopsy.&lt;br /&gt;&lt;br /&gt;In population screened situations, where a raised PSA is reported, a common clinical staging, utilizing the TNM classification, is T1c, which is tumor identified by needle biopsy. &lt;br /&gt;&lt;br /&gt;However, when prostate cancer is found prior to biopsy, through the application of newer imaging techniques of the prostate, such as dynamic contrast-enhanced MR imaging and 3D MR spectroscopic imaging, and that prostate cancer is confirmed by subsequent biopsy, would the clinical staging, prior to treatment, still remain T1, or could the clinical stage be up-graded to reflect a T2 or even T3 classification depending on the imaging results?&lt;br /&gt;&lt;br /&gt;In other words, given that "magnetic imaging is now widely used for staging before treatment and accumulating data indicate the utility of this technique with magnetic resonance spectroscopy in staging and follow-up" , ( Imaging of Prostate Cancer. Oehr P, Bouchelouche K, Curr Opin Oncol. 2007 May;19(3):259-64) can the staging system reflect this improved imaging so as to better delineate T1 from T2 and T3 classification?&lt;br /&gt;&lt;br /&gt;Thank you for your expertise,&lt;br /&gt;&lt;br /&gt;David&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="color: rgb(51, 51, 51);  font-style: italic; line-height: 18px;font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-style: italic; line-height: 18px; "&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;The answer is yes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="line-height: normal; "&gt;&lt;a name="Primary" style="font-weight: bold; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;Below you find the official and current &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page4#Section_18"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;TNM staging system issued by AJCC 2002&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt; (&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="line-height: normal; -webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;The American Joint Committee on Cancer (AJCC) TNM staging system for Prostate, 6th edition). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style="line-height: normal; -webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;There it is defined clearly:" &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; "&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;T1: Clinically inapparent tumor not palpable nor visible by imagi&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;n&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;g...&lt;/span&gt;&lt;span class="Apple-style-span"  style="color: rgb(0, 0, 0);  font-weight: normal; font-family:Georgia;"&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;Tumor found in 1 or both lobes by needle biopsy, but not palpable &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-weight: bold; "&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;or reliably visible by imaging&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;, is classified as T1c."&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="color: rgb(51, 51, 51); font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;In other words, &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;if reliably seen on Ultrasound or MRI, the tumor stage changes to T2 or T3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;, even if the tumor is not palpable (= the tumor is not felt by the urologist during the digital rectal examination).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: 'trebuchet ms';"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="color: rgb(51, 51, 51); font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;a href="http://www.meb.uni-bonn.de/cancer.gov/Media/CDR0000442273.jpg"&gt;See illustrations from the National Cancer Institute (NCI)&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style=";font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style=";font-family:'trebuchet ms';"&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span" style="color: rgb(77, 77, 77); line-height: normal; "&gt;&lt;a name="Content" style="font-weight: bold; text-decoration: underline; color: rgb(255, 102, 0); "&gt;&lt;table width="571" cellspacing="0" cellpadding="0" border="0" style="border-top-width: 0px; border-right-width: 0px; border-bottom-width: 0px; border-left-width: 0px; color: rgb(51, 51, 51); width: 100%; "&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign="top" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; border-top-width: 0px; border-right-width: 0px; border-bottom-width: 0px; border-left-width: 0px; padding-top: 0px; padding-right: 0px; padding-bottom: 0.4em; padding-left: 0px; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; line-height: 1.5em; vertical-align: middle; "&gt;&lt;span class="Summary-SummarySection-Title-Level2" style="color: rgb(0, 0, 0); font-weight: bold; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a href="http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page4#Section_18"&gt;TNM Definitions&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_20" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Protocol-IL-Title" style="font-weight: bold; font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Primary tumor (T)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul __id="_20" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;TX: Primary tumor cannot be assessed&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T0: No evidence of primary tumor&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T1: Clinically inapparent tumor not palpable nor visible by imaging&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_21" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;ul __id="_21" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T1a: Tumor incidental histologic finding in 5% or less of tissue resected&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T1b: Tumor incidental histologic finding in more than 5% of tissue resected&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T2: Tumor confined within prostate*&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_24" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;ul __id="_24" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T2a: Tumor involves 50% or less of one lobe&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T2b: Tumor involves more than 50% of one lobe but not both lobes&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T2c: Tumor involves both lobes&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T3: Tumor extends through the prostate capsule**&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_25" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;ul __id="_25" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T3a: Extracapsular extension (unilateral or bilateral)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T3b: Tumor invades seminal vesicle(s)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;T4: Tumor is fixed or invades adjacent structures other than seminal vesicles: bladder neck, external sphincter, rectum, levator muscles, and/or pelvic wall&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_239" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p __id="_239" style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;* [&lt;/span&gt;&lt;/span&gt;&lt;span class="Protocol-Note" style="font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Note: Tumor that is found in one or both lobes by needle biopsy but is not palpable or reliably visible by imaging is classified as T1c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_240" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p __id="_240" style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;** [&lt;/span&gt;&lt;/span&gt;&lt;span class="Protocol-Note" style="font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Note: Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is classified as T2 not T3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_205" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Protocol-IL-Title" style="font-weight: bold; font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Regional lymph nodes (N)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul __id="_205" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Regional lymph nodes are the nodes of the true pelvis, which essentially are the pelvic nodes below the bifurcation of the common iliac arteries. They include the following groups (laterality does not affect the N classification): pelvic (not otherwise specified [NOS]), hypogastric, obturator, iliac (i.e., internal, external, or NOS), and sacral (lateral, presacral, promontory [e.g., Gerota], or NOS). Distant lymph nodes are outside the confines of the true pelvis. They can be imaged using ultrasound, CT, MRI, or lymphangiography and include: aortic (para-aortic, periaortic, or lumbar), common iliac, inguinal (deep), superficial inguinal (femoral), supraclavicular, cervical, scalene, and retroperitoneal (NOS) nodes. Although enlarged lymph nodes can occasionally be visualized, because of a stage migration associated with PSA screening, very few patients will be found to have nodal disease, so false-positive and false-negative results are common when imaging tests are employed. In lieu of imaging, risk tables are generally used to determine individual patient risk of nodal involvement. Involvement of distant lymph nodes is classified as M1a.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_222" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;ul __id="_222" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;NX: Regional lymph nodes were not assessed&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;N0: No regional lymph node metastasis&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;N1: Metastasis in regional lymph node(s)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_34" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Protocol-IL-Title" style="font-weight: bold; font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Distant metastasis (M)*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul __id="_34" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;MX: Distant metastasis cannot be assessed (not evaluated by any modality)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;M0: No distant metastasis&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;M1: Distant metastasis&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_35" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;ul __id="_35" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;M1a: Nonregional lymph node(s)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;M1b: Bone(s)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Dash" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;M1c: Other site(s) with or without bone disease&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="END_ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_36" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p __id="_36" style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;* [&lt;/span&gt;&lt;/span&gt;&lt;span class="Protocol-Note" style="font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Note: When more than one site of metastasis is present, the most advanced category (pM1c) is used.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="Section_38" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;a name="ListSection" style="font-weight: bold; color: rgb(51, 102, 204); "&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;p style="font-weight: normal; text-decoration: none; color: rgb(51, 51, 51); "&gt;&lt;span class="Protocol-IL-Title" style="font-weight: bold; font-style: italic; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;Histopathologic grade (G)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul __id="_38" class="Protocol-UL" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; margin-top: 5px; margin-bottom: 5px; "&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;GX: Grade cannot be assessed&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;G1: Well differentiated (slight anaplasia) (Gleason score of 2–4)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;G2: Moderately differentiated (moderate anaplasia) (Gleason score of 5–6)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="Protocol-IL-Bullet" style="color: rgb(77, 77, 77); font-weight: normal; text-decoration: none; list-style-image: url(http://www.cancer.gov/images/bullet_sm_css.gif); list-style-position: initial; list-style-type: disc; margin-left: -15px; padding-left: -15px; "&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;G3-4: Poorly differentiated or undifferentiated (marked anaplasia) (Gleason score of 7–10)&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 18px; "&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'trebuchet ms';"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"   style="color: rgb(51, 51, 51);   line-height: 18px;font-family:'Trebuchet MS';font-size:13px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2263535795386733843-2128247141282647243?l=prostate-forum.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://prostate-forum.blogspot.com/feeds/2128247141282647243/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=2263535795386733843&amp;postID=2128247141282647243' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2128247141282647243'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2128247141282647243'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/2008/02/could-clinical-stage-be-up-graded-to.html' title='&quot;...could the clinical stage be up-graded to reflect a T2 or even T3 classification depending on the imaging results?&quot;'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2263535795386733843.post-2297745236870797005</id><published>2008-01-31T22:54:00.000-05:00</published><updated>2008-02-01T00:48:13.323-05:00</updated><title type='text'>If PSA of 3 can still indicate cancer, why is only a PSA &gt; 4 suspicious?</title><content type='html'>...an anonymous reader asked.&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;A PSA level of 3 &lt;span class="Apple-style-span" style="font-weight: bold;"&gt;does not &lt;/span&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;indicate&lt;/span&gt;&lt;/span&gt; cancer. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Yet, it is &lt;span class="Apple-style-span" style="font-style: italic;"&gt;possible&lt;/span&gt; to have a PSA of 3  with prostate cancer. &lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;div&gt;&lt;div&gt;PSA is a very successful screening test, and helped to detect and treat prostate cancer earlier. &lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;div&gt;However, to make this screening test successful and efficient, thresholds had to be established.&lt;/div&gt;&lt;div&gt;Based on several very large studies these thresholds were set, because it was found, that with PSA levels below 4 the risk for prostate cancer is &lt;span class="Apple-style-span" style="font-style: italic;"&gt;relatively&lt;/span&gt; low (see previous &lt;a href="http://prostate-forum.blogspot.com/2008/01/does-psa-level-of-6-mean-that-prostate.html"&gt;post Jan 28&lt;/a&gt;).&lt;/div&gt;&lt;div&gt;With PSA levels above 4 the risk was significantly higher.&lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;div&gt;These are statistical - empirical values. &lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;div&gt;However, it is obvious,  that by setting a "threshold" (or cut-off) based on &lt;span class="Apple-style-span" style=""&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;statistics&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt; (&lt;span class="Apple-style-span" style="font-weight: bold;"&gt;in contrast to personalized medicine&lt;/span&gt;)&lt;/span&gt;, we always will have some patients who fall into the low risk group and do have cancer; and will find many patients with "elevated PSA" who have no cancer.&lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2263535795386733843-2297745236870797005?l=prostate-forum.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://prostate-forum.blogspot.com/feeds/2297745236870797005/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=2263535795386733843&amp;postID=2297745236870797005' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2297745236870797005'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2297745236870797005'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/2008/01/if-psa-of-3-can-still-indicate-cancer.html' title='If PSA of 3 can still indicate cancer, why is only a PSA &gt; 4 suspicious?'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2263535795386733843.post-2799598983043264201</id><published>2008-01-31T20:12:00.000-05:00</published><updated>2008-02-06T22:42:02.657-05:00</updated><title type='text'>"If PSA is elevated, can ultrasound or MRI rule out cancer ?"</title><content type='html'>...was asked by an anonymous reader.&lt;div&gt;&lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Neither Ultrasound nor MRI  can role out cancer &lt;span class="Apple-style-span" style="font-weight: bold;"&gt;completely&lt;/span&gt;. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;Ultrasound&lt;/span&gt;: is very useful to visualize the prostate during biopsy and other interventions. &lt;/div&gt;&lt;div&gt;However, the prostate borders are not clearly seen.  Cancer, if big enough  and in locations closer to the rectum, can be seen, but not always.  New developments in ultrasound, especially contrast enhancement (a contrast agent is injected into the arm vein  - like in CT or MRI), and other new techniques, (currently investigated in research studies)  seem to make ultrasound better. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-style: italic;"&gt;MRI&lt;/span&gt;: is by far the best imaging modality for prostate at the moment. When performed right, the prostate gland, the capsule of the gland, the structures  around the prostate (like the neurovascular bundles and seminal vesicles) can be seen clearly; and cancer is much better seen on MRI than on Ultrasound or CT. If state-of-the-art MR imaging protocols are used, which include &lt;a href="http://www.imagingeconomics.com/issues/articles/2005-10_08.asp"&gt;dynamic contrast enhanced MRI&lt;/a&gt;, or &lt;a href="http://www.ustoo.org/PDFs/HotSheets/HotSheet052007.pdf"&gt;MR Spectroscopy&lt;/a&gt;, the results are even better, and most of the clinical relevant cancer are seen. With clinical relevant cancers are seen is meant, that tumors, which need clinical treatment, are picked up with MRI in most of the cases (up to 90-95% in experienced prostate MRI centers). MRI is not perfect (nothing is): very small tumors and in some cases even larger tumors are still not seen with MRI. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Therefore, cancer can never be excluded completely. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;However,  if the PSA-level is elevated, yet, the experienced Urologist does not "feel" the cancer during his digital rectal exam (DRE; the urologist examines the prostate with his finger through the rectum); the Ultrasound is negative (does not show any suspicious area); and the MRI does not show any tumor, the chance that there is a cancer present, which needs immediate therapy is drastically reduced.  The urologist has to decide then, if he wants to perform a biopsy or not:  based on the patients history, PSA, DRE, findings on ultrasound and  - if performed  - findings of MRI. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;The advantages of prostate MRI are described and explained on several websites (see links on the right side). Currently,  MRI is generally performed only &lt;span class="Apple-style-span" style="font-style: italic;"&gt;after&lt;/span&gt; cancer has been diagnosed with biopsy (for staging; is the cancer gland confined or not?); or after repeat negative biopsies and rising PSA (for detection); or after therapy and PSA relapse (for local recurrence).&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2263535795386733843-2799598983043264201?l=prostate-forum.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://prostate-forum.blogspot.com/feeds/2799598983043264201/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=2263535795386733843&amp;postID=2799598983043264201' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2799598983043264201'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2799598983043264201'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/2008/01/if-psa-is-elevated-can-ultrasound-or.html' title='&quot;If PSA is elevated, can ultrasound or MRI rule out cancer ?&quot;'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2263535795386733843.post-2735848843570185974</id><published>2008-01-28T20:55:00.000-05:00</published><updated>2008-01-30T19:22:05.470-05:00</updated><title type='text'>"Does a PSA level of 6 mean that prostate cancer exists??"</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;This questions was asked by an anonymous person.&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Thank you for this very important question!&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The answer is no. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;But cancer is possible and further investigation (clinical exams) is necessary.  &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;[On the other hand, cancer is also possible with a PSA (Prostate Specific Antigen) level of 3]. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;PSA levels can be elevated due to several reasons: cancer, benign prostatic hyperplasia (enlargement of the prostate - in elder men; larger prostates produce more PSA), inflammation/infection (prostatitis), mechanical irritation (e.g. horse or bicycle riding), and ejaculation, and others.  &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;However, in case PSA is elevated further exams are indicated.  [a PSA level of 6  - before we know the size of the prostate  - has to be considered as elevated; levels between 4-10 are suspicious]: &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;1) Digital rectal exam (DRE; Urologists examine manually the prostate), 2) trans-rectal ultrasound (TRUS), or 3) MRI (magnetic resonance imaging). &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Based on the results  of these exams, a decision has to be made if biopsy is necessary at this point.  &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;In other words: &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="line-height: 19px; "&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;PSA levels between 4 and 10 ng/mL (nanograms per milliliter) are considered to be suspicious and should be followed by trans-rectal &lt;/span&gt;&lt;/span&gt;&lt;a href="http://en.wikipedia.org/wiki/Medical_ultrasonography" title="Medical ultrasonography" style="text-decoration: none; background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; "&gt;&lt;span class="Apple-style-span" style="color: rgb(0, 0, 0);"&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;ultrasound &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;imaging and, if indicated, &lt;/span&gt;&lt;/span&gt;&lt;a href="http://en.wikipedia.org/wiki/Prostate_biopsy" title="Prostate biopsy" style="text-decoration: none; background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; "&gt;&lt;span class="Apple-style-span" style="color: rgb(0, 0, 0);"&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;prostate biopsy should be performed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;. Some urologists prefer to ask for MR Imaging prior to the biopsy to better locate any suspicious, "cancerous" area, and consequently target the biopsy.  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 19px; "&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 19px; "&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;PSA is an excellent screening test and helps to detect prostate cancer early. Yet, PSA is false positive-prone (7 out of 10 men with PSA levels 4-10 will still not have prostate cancer) and false negative-prone (2-3 out of 10 men with prostate cancer have no elevation in PSA).&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; Recent reports indicate that refraining from ejaculation 24 hours or more prior to testing will improve test accuracy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2263535795386733843-2735848843570185974?l=prostate-forum.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://prostate-forum.blogspot.com/feeds/2735848843570185974/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=2263535795386733843&amp;postID=2735848843570185974' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2735848843570185974'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/2735848843570185974'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/2008/01/does-psa-level-of-6-mean-that-prostate.html' title='&quot;Does a PSA level of 6 mean that prostate cancer exists??&quot;'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2263535795386733843.post-7127450893454966257</id><published>2008-01-08T15:05:00.000-05:00</published><updated>2008-01-08T15:12:11.947-05:00</updated><title type='text'>This blog was created for patients, technologists, clinicians and radiologists to address questions and ideas about prostate imaging.</title><content type='html'>&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2263535795386733843-7127450893454966257?l=prostate-forum.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://prostate-forum.blogspot.com/feeds/7127450893454966257/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=2263535795386733843&amp;postID=7127450893454966257' title='5 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/7127450893454966257'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/7127450893454966257'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/2008/01/this-blog-was-created-for-patients.html' title='This blog was created for patients, technologists, clinicians and radiologists to address questions and ideas about prostate imaging.'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>5</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2263535795386733843.post-3755250865390970934</id><published>2008-01-01T17:33:00.000-05:00</published><updated>2008-02-01T00:41:10.029-05:00</updated><title type='text'>DISCLAIMER</title><content type='html'>&lt;!--StartFragment--&gt;  &lt;p class="MsoNormal" style="margin-bottom:10.0pt;line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Terms of Use Agreement&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;This Terms of Use Agreement (this “Agreement”) is entered into by and between Nicolas Bloch,&lt;/span&gt;&lt;/span&gt;&lt;span style="mso-spacerun: yes"&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;(the “Author”) and “you,” the user of this web blog, also known as the “Prostate Cancer Imaging Forum” (the “Site”). Access to, use of and/or browsing of the Site is provided subject to the terms and conditions set forth herein. By accessing, using and/or browsing the Site, you hereby agree to these terms and conditions.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;THIS AGREEMENT CONTAINS WARRANTY DISCLAIMERS AND OTHER PROVISIONS THAT LIMIT THE AUTHOR’S LIABILITY TO YOU. PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY AND IN THEIR ENTIRETY, AS USING, ACCESSING AND/OR BROWSING THE SITE CONSTITUTES ACCEPTANCE OF THESE TERMS AND CONDITIONS. IF YOU DO NOT AGREE TO BE BOUND TO EACH AND EVERY TERM AND CONDITION SET FORTH HEREIN, PLEASE EXIT THE SITE IMMEDIATELY AND DO NOT USE, ACCESS AND/OR BROWSE THE SITE.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;BY ENTERING THE SITE, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE READ AND UNDERSTAND THESE TERMS AND CONDITIONS, THAT THE PROVISIONS, DISCLOSURES AND DISCLAIMERS SET FORTH HEREIN ARE FAIR AND REASONABLE, AND THAT YOUR AGREEMENT TO FOLLOW AND BE BOUND BY THESE TERMS AND CONDITIONS IS VOLUNTARY AND IS NOT THE RESULT OF FRAUD, DURESS OR UNDUE INFLUENCE EXERCISED UPON YOU BY ANY PERSON OR ENTITY.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;MEDICAL ADVICE DISCLAIMER &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Author provides the Site and the services, information, content and/or data (collectively, “Information”) contained therein for informational purposes only. The Author does not provide any medical advice on the Site, and the Information should not be so construed or used. Using, accessing and/or browsing the Site and/or providing personal or medical information to the Author does not create a physician-patient relationship between you and the Author. Nothing contained in the Site is intended to create a physician-patient relationship, to replace the services of a licensed, trained physician or health professional or to be a substitute for medical advice of a physician or trained health professional licensed in your state. You should not rely on anything contained in the Site, and you should consult a physician licensed in your state in all matters relating to your health. You hereby agree that you shall not make any health or medical related decision based in whole or in part on anything contained in the Site.&lt;/span&gt;&lt;/span&gt;&lt;o:p&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span" style="  line-height: normal; "&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;FINANCIAL, LEGAL AND OTHER ADVICE DISCLAIMER&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;You hereby acknowledge that nothing contained in the Site shall constitute financial, investment, legal and/or other professional advice and that no professional relationship of any kind is created between you and the Author. You hereby agree that you shall not make any financial, investment, legal and/or other decision based in whole or in part on anything contained in the Site.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;INFORMATION DISCLAIMER&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The opinions expressed in the Site are not necessarily the opinions of the Author and do not necessarily reflect the opinion of his employer(s). The Site is created by the Author in the Author’s individual capacity, is the Author’s personal web site, is not edited by the Author’s employer(s) and, as a result, may not be attributed to the Author’s employer.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Any opinions of the Author on the Site are or have been rendered based on specific facts, under certain conditions, and subject to certain assumptions, and may not and should not be used or relied upon for any other purpose, including, but not limited to, for use in or in connection with any legal proceeding.&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Information may be changed without notice and is not guaranteed to be complete, correct, timely, current or up-to-date. Similar to any printed materials, the Information may become out-of-date. The Author undertakes no obligation to update any Information on the Site; provided, however, that the Author may update the Information at any time without notice in the Author’s sole and absolute discretion. The Author reserves the right to make alterations or deletions to the Information at any time without notice.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;POSTING GUIDELINES&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Site is open to the public. Therefore, consider your comments carefully and do not include anything in a comment that you would like to keep private. By uploading or otherwise making available any information to the Author in the form of user generated comments or otherwise, you grant the Author the unlimited, perpetual right to distribute, display, publish, reproduce, reuse and copy the information contained therein.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;You are responsible for the content you post. You may not impersonate any other person through the Site. You may not post content that is obscene, defamatory, threatening, fraudulent, invasive of another person’s privacy rights, or is otherwise unlawful. You may not post content that infringes the intellectual property rights of any other person or entity. You may not post any content that contains any computer viruses or any other code designed to disrupt, damage, or limit the functioning of any computer software or hardware.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;By submitting or posting content on the Site, you grant the Author and any company substantially under the control of the Author, the right to remove any content or comment that, in Author’s sole judgment, does not comply with the terms and conditions of this Agreement or is otherwise objectionable. You also grant the Author and any company substantially under the control of Author the right to modify, adapt, and edit any content.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;THIRD PARTY LINKS AND ADVERTISEMENTS DISCLAIMER&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Site may, from time to time, contain links to third party web sites. These links are provided solely as a convenience to you and not as a guarantee, warranty, or recommendation by the Author of the services, information, content and/or data on such third party web sites or as an indication of any affiliation, sponsorship or endorsement of such third party web sites. The Author is not responsible for the content of linked third party web sites and does not make any representations or warranties regarding the privacy practices of, or the content or accuracy of materials on, such third party websites. If you decide to access linked third-party web sites, you do so at your own risk. Your use of third-party websites is subject to the terms of use for such sites.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;THE INCLUSION OF THIRD PARTY ADVERTISEMENTS DOES NOT CONSTITUTE AN ENDORSEMENT, GUARANTEE, WARRANTY, OR RECOMMENDATION OF, AND THE AUTHOR MAKES NO REPRESENTATIONS AND/OR WARRANTIES ABOUT, ANY PRODUCT OR SERVICE CONTAINED THEREIN.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;DISCLAIMER OF ALL WARRANTIES &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Information made available at the Site is provided on an “AS IS” and “AS AVAILABLE” basis without warranties of any kind, either express or implied, including, without limitation, warranties of title, noninfringement, and implied warranties of merchantability or fitness for a particular purpose. Without limiting the generality of the foregoing, the Author makes no warranty, representation or guaranty as to the content, sequence, accuracy, timeliness or completeness of the Information, that the Information may be relied upon for any reason or that the Information will be uninterrupted or error free or that any defects can or will be corrected.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Without limiting the generality of the foregoing, the Author makes no representations or warranties with respect to any Information offered or provided within or through the Site regarding treatment of medical conditions, action, or application of medication.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Under no circumstances, as a result of your use of the Site, will the Author be liable to you or to any other person for any direct, indirect, special, incidental, exemplary, consequential or other damages under any legal theory, including, without limitation, tort, contract, strict liability or otherwise, even if advised of the possibility of such damages. Without limiting the generality of the foregoing, the Author shall have absolutely no liability in connection with the Site for:&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;1. damages as a result of lost profits, loss of good will, work stoppage, failure of performance, delays in operation or transmission, nondelivery of information, deletions of files, mistakes, defects, errors, interruptions or computer failure or malfunction;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;2. any loss or injury caused, in whole or in part, by the Author’s actions, omissions, or negligence, or for contingencies beyond the Author’s control, in procuring, compiling, or delivering the Information;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;3. any errors, omissions, or inaccuracies in the Information regardless of how caused, or delays or interruptions in delivery of the Information; or&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;4. any decision made or action taken or not taken in reliance upon the Information.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;RESERVATION OF INTELLECTUAL PROPERTY RIGHTS&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Site is protected by United States copyright laws. The Author hereby reserves any and all intellectual property rights in the Site.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;AGE RESTRICTION&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Site is intended for persons eighteen (18) years or older. Persons under the age of eighteen (18) should not access, use and/or browse the Site.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;INDEMNIFICATION&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;You agree to indemnify and hold the Author harmless from any claim or demand, including attorneys’ fees, made by any third party as a result of (1) any content posted or made available by you on this Site, (2) any violation of law that occurs by you through the Site, and/or (3) anything you do using the Site and/or the Information contained therein.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;INVALIDITY&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;If any provision of this Agreement is held to be invalid or unenforceable in whole or in part in any jurisdiction, then that provision shall be deemed ineffective in such jurisdiction but shall have no effect on the enforceability of the remaining provisions.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;GOVERNING LAW, CONSENT TO JURISDICTION AND LIMITATION ON CLAIMS&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;This Agreement and your use of the Site, along with the Information contained therein, shall be governed by and construed in accordance with the laws of the State of New Hampshire without regard to conflict of laws principles, and you agree to submit to the jurisdiction of courts in the State of New Hampshire. You further agree that any claims or causes of action arising out of or related to this Agreement and the Site, along with the Information contained therein, shall be filed within one (1) year after such claim or cause of action arose, or such claim or cause of action shall be forever barred.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;ENTIRE AGREEMENT&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;You hereby acknowledge that this Agreement represents the entire understanding between you and the Author concerning your use of the Site and the Information contained therein.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;MODIFICATION&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Author may, in the Author’s sole and absolute discretion, modify the terms and conditions of this Agreement in whole or in party at any time for any reason without any notice to you, whether prior or otherwise. Such modified terms and conditions shall supersede these terms and conditions and shall become binding when published online on the Site.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;WAIVER&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;The Author’s failure to exercise or enforce any right or provision of this Agreement shall not be deemed to be a waiver of such right or provision.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="line-height:20.0pt;mso-pagination:none;mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51);"&gt;&lt;span class="Apple-style-span" style="font-family: verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;THE SITE AND THE INFORMATION CONTAINED THEREIN IS MADE AVAILABLE BY THE AUTHOR FOR EDUCATIONAL PURPOSES ONLY AND IS NOT INTENDED TO PROVIDE MEDICAL ADVICE. BY ACCESSING THE SITE, YOU UNDERSTAND AND ACKNOWLEDGE THAT THERE IS NO PHYSICIAN-PATIENT RELATIONSHIP BETWEEN YOU AND THE AUTHOR. YOU FURTHER ACKNOWLEDGE YOUR UNDERSTANDING THAT THE SITE SHOULD NOT BE USED AS A SUBSTITUTE FOR COMPETENT MEDICAL ADVICE FROM A LICENSED PHYSICIAN IN YOUR STATE.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;!--EndFragment--&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2263535795386733843-3755250865390970934?l=prostate-forum.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/3755250865390970934'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2263535795386733843/posts/default/3755250865390970934'/><link rel='alternate' type='text/html' href='http://prostate-forum.blogspot.com/2008/01/disclaimer.html' title='DISCLAIMER'/><author><name>Nicolas Bloch</name><uri>http://www.blogger.com/profile/08819684292144942002</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry></feed>
